Human VEGF QuantiGlo ELISA Kit | R&D Systems QVE00B product information

product summary

company name :

R&D Systems

product type :

ELISA/assay

product name :

Human VEGF QuantiGlo ELISA Kit

catalog :

QVE00B

quantity :

1 Kit

price :

770 USD

more info or order :

R&D Systems product webpage

citations: 23

Reference
Aries A, Vignon C, Zanetti C, Goubaud A, Cormier A, Diederichs A, et al. Development of a potency assay for CD34+ cell-based therapy. Sci Rep. 2023;13:19665 pubmed publisher
Fu J, Shinjo T, Li Q, St Louis R, Park K, Yu M, et al. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy. JCI Insight. 2022;7: pubmed publisher
Abrahamsson A, Capodanno A, Rzepecka A, Dabrosin C. Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women. Oncotarget. 2017;8:92134-92142 pubmed publisher
Xie M, Dart D, Guo T, Xing X, Cheng X, Du H, et al. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer. 2018;21:41-54 pubmed publisher
Bader A, Klose K, Bieback K, Korinth D, Schneider M, Seifert M, et al. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro. PLoS ONE. 2015;10:e0138477 pubmed publisher
Lecce L, Lam Y, Lindsay L, Yuen S, Simpson P, Handelsman D, et al. Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis. Mol Endocrinol. 2014;28:1487-501 pubmed publisher
Abu El Asrar A, Nawaz M, Kangave D, Mairaj Siddiquei M, Geboes K. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res. 2013;2013:539658 pubmed publisher
Leifler K, Svensson S, Abrahamsson A, Bendrik C, Robertson J, Gauldie J, et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J Immunol. 2013;190:4420-30 pubmed publisher
Gupta P, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation. 2011;8:47 pubmed publisher
Chambers S, Clouser M, Baker A, Roe D, Cui H, Brewer M, et al. Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin Cancer Res. 2010;16:5320-8 pubmed publisher
Saarinen N, Warri A, Dings R, Airio M, Smeds A, MAKELA S. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int J Cancer. 2008;123:1196-204 pubmed publisher
Bendrik C, Robertson J, Gauldie J, Dabrosin C. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008;68:3405-12 pubmed publisher
Etto L, Lacerda E, Baiocchi O, Silva V, Dalboni M, Alves A, et al. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2008;49:257-64 pubmed publisher
Carroll V, Ashcroft M. Regulation of angiogenic factors by HDM2 in renal cell carcinoma. Cancer Res. 2008;68:545-52 pubmed publisher
Anelli V, Gault C, Cheng A, Obeid L. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem. 2008;283:3365-75 pubmed
Kut C, Mac Gabhann F, Popel A. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer. 2007;97:978-85 pubmed
Chen Y, Hu Y, Lu K, Flannery J, Ma J. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem. 2007;282:34420-8 pubmed
Sutton K, Hayat S, Chau N, Cook S, Pouyssegur J, Ahmed A, et al. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene. 2007;26:3920-9 pubmed
Carroll V, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res. 2006;66:6264-70 pubmed
Liu Y, Mueller B. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun. 2006;344:1263-70 pubmed
Feltis B, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med. 2006;173:1201-7 pubmed
Cartwright L, Farhat W, Sherman C, Chen J, Babyn P, Yeger H, et al. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A. 2006;77:390-5 pubmed
Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik S, et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 2005;65:7249-58 pubmed

image

image 1 :

Human VEGF Chemiluminescent ELISA Cell Culture Supernate/Serum/Plasma/Saliva Standard Curve

product information

brand :

R&D Systems

master code :

QVE00B

SKU :

QVE00B

product name :

Human VEGF QuantiGlo ELISA Kit

unit size :

1 Kit

seo description :

The Human VEGF QuantiGlo ELISA Kit from R&D Systems quantifies human VEGF in cell culture supernates (50 ul), serum (50 ul), edta plasma (50 ul), heparin plasma (50 ul), saliva (50 ul), urine (50 ul).

target :

VEGF

category :

ELISAs

dilution :

ELISA

species :

Human

specificity :

Natural and recombinant human VEGF. This assay also recognizes recombinant human VEGF165b.

gene symbol :

VEGFA

assay length :

5.5 hours

elisaSampleTypes :

Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL), Saliva (50 uL), Urine (50 uL)

elisaSensitivity :

5.99 pg/mL

elisaRange :

6.40 - 20000 pg/mL

top caption :

Human VEGF Chemiluminescent ELISA Cell Culture Supernate/Serum/Plasma/Saliva Standard Curve

applications :

ELISA

USD :

770 USD

product details :

The QuantiGlo Human VEGF Chemiluminescent Immunoassay is a 5.5 hour solid phase ELISA designed to measure VEGF165 levels in cell culture supernates, serum, plasma, saliva, and urine. It contains Sf 21-expressed recombinant human VEGF165 and antibodies raised against the recombinant protein. Results obtained for naturally occurring human VEGF and recombinant human VEGF121 showed linear curves that were parallel to the standard curves obtained using the QuantiGlo kit standards. These results indicate that this kit can be used to determine relative mass values for natural human VEGF.

alt names :

MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor

storage :

Store the unopened product at 2 - 8 ░C. Do not use past expiration date.

more info or order :

R&D Systems product webpage